Skip to main content
Premium Trial:

Request an Annual Quote

Research and Markets RNAi2004: Strategic Opportunities

Premium

Research and Markets said that it has released an RNAi market analysis report entitled “RNAi2004: Strategic Opportunities.”

The report, said Research and Markets, includes interviews with experts; evaluations of leading companies; qualitative and quantitative market models across multiple segments of the RNAi value chain; and strategic recommendations for capitalizing on specific opportunities.

The report, the company added, also highlights three segments of the RNAi marketplace: the synthesis and validation for siRNAs; siRNA delivery; and detection and analysis of knockdown.

Details about purchasing the report can be found at http://www.researchandmarkets.com/reports/c1419/.

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Charged with Sanction Violations

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.